secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALATIN TECHNOLOGIES INC (PTN)
CIK:        0000911216
Form:       8-K
Filed at:   2023-10-19T23:59:59+00:00
Accession:  0001654954-23-013131
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Palatin prelim Q1: Vyleesi gross revenue $4.6M, net $2.1M, up 100% and 137% YoY
-------------------------------------------------------------------------------

- Gross product revenue $4.6M (+11% qoq, +100% YoY); net product revenue $2.1M (+18% qoq, +137% YoY).
- Prescriptions dispensed grew 14% over prior quarter and 88% over comparable quarter last year.
- Seventh consecutive quarter of double-digit growth in product revenue and prescriptions dispensed.
- CEO reports net revenue per prescription improving; net product revenue exceeds Vyleesi quarterly operating expenses.
- All key metrics (new patient starts, refill rates, insurance reimbursement, new prescribers) showed positive trends.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/911216/000165495423013131/0001654954-23-013131-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/911216/000165495423013131/ptn_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-013131

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer